Clinical trial Recruiting at 6 sites Observational Ages 18 and up Women only

Evaluating the long-term effects of Splentis for treating pelvic organ prolapse

Official title: Prospective, Multicenter, 60 Months, Single-arm Cohort Trial for Evaluation of the Efficacy and Safety of Transvaginal Sacrospinous Ligament Fixation With Splentis for the Treatment of Primary Apical Pelvic Organ Prolapse

Run by Promedon · NCT05042453 · Data updated 2026-11-12

This study is testing how well the Splentis system works for treating uterine prolapse in women over five years, looking at both how they feel and any side effects they might have.

More Pelvic Organ Prolapse trials

Quick facts

Study typeObservational
Ages18 Years and up
SexWomen only
Enrollment140 (estimated)
SponsorPromedon
Industry-sponsored
Drugs / interventionsradiation
Locations7 sites (Chemnitz and 6 other locations)
StatusRecruiting
StartedDecember 19, 2022
Main results expectedJuly 2026
Study endsJuly 2030
Registry record updatedNovember 22, 2024
Trial IDNCT05042453 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are non-fertile women with primary symptomatic uterine descent and a POP-Q score of 2 or higher scheduled for apical repair.

Probably not a fit

Patients with recurrent apical prolapse or those with active infections or a history of pelvic cancer may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational cohort trial aims to assess the long-term efficacy and safety of hysteropexy using the Splentis system for women with primary uterine prolapse. Participants will undergo the procedure via the vaginal route and will be followed for 60 months to evaluate various outcomes, including anatomical success, subjective satisfaction, and the need for re-treatment. Secondary endpoints will focus on functional outcomes such as urinary incontinence, overactive bladder symptoms, quality of life, and sexual health, along with a comprehensive report on any adverse events experienced during the study.

Why it matters

Potential benefit: If successful, this study could provide a new effective treatment option for women suffering from primary pelvic organ prolapse.

How similar studies have gone: While this approach is being evaluated in this trial, similar studies have shown promising results with other surgical techniques for pelvic organ prolapse.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* non-fertile women
* primary symptomatic uterine descent POP-Q≥2
* Scheduled apical POP repair with Splentis
* Willing and able to participate at study visits and to sign informed consent

Exclusion Criteria:

* Fertile women
* Recurrent apical prolapse
* Women with post hysterectomy vaginal vault prolapse
* Patients with active or latent infection of the vagina, cervix or uterus
* Patients with previous or current vaginal, cervical or uterine cancer
* Previous, current or planned pelvic radiation therapy
* Known allergy to polypropylene.

Where it's running

  • DRK Hospital Chemnitz-Rabenstein
    Chemnitz, Germany
    Recruiting
  • Helios Hospital Erfurt, Department of gynaecology
    Erfurt, Germany
    Recruiting
  • University Hospital Freiburg
    Freiburg im Breisgau, Germany
    Recruiting
  • Clinic Kassel
    Kassel, Germany
    Recruiting
  • St. Elisabeth Hospital
    Leipzig, Germany
    Recruiting
  • Hospital Tettnang
    Tettnang, Germany
    Recruiting
Show 1 more location
  • University Hospital
    Mannheim, Germany
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.